Daily happenings?., page-524

First 524 Last

Share
Profile

Follow
CompleteBull

40 Posts.

256

04/07/24

14:17

Post #: 74608151
Share

Originally posted by gavncath: ↑

Thanks Supertramp... I'd agree with you, but my approach is to use my background in medicine and spend a truck load of hours researching. Even then it is rare that I'll invest. Once I'm convinced of the science, the IP and the company finances, only then do I go and meet the CEO and see if I can find issues on the people side... if I find none, then I buy in as hard as I can (without borrowing nor risking the house)... from there the strategy is to keep reading to see if there is other science that will beat what they have and regularly re-assessing the investment. From my reading I haven't seen anything that beats what Omnicar should be able to do... PTX100/CellPryme are less interesting to me but still potentially impressive assets.
Currently I'm down an absolute truck load of money on PTX, (as are the vast majority of my friends... sorry everyone) but I was in the same position with Polynovo and that ended up being my most fun investment... time will tell.
Gav

Expand

Hi Gavncath,

Very interesting. Long time no see.

I too am in PTX for OmniCar. Lot of shares. However, we haven't heard anything since "oh, tonic signally seems a bit of an issue. We need to solve."

Appreciate if you could provide your analysis and thoughts based on your experience in medicine and previous track record, and likely connections. Where is OmniCar and when / will it be back??

Cheers
CB

PTX Price at posting: 4.2¢ Sentiment: Buy Disclosure: Held
4 Upvote

1 Great analysis

Reply

Top Stories

PL3

Patagonia looks to raise $2.15M for South American exploration and development

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

There are more pages in this discussion • 1 more message in this thread...

First 524 Last

Add PTX (ASX) to my watchlist

(20min delay)
Last 4.4¢		Change 0.003(7.32%)		Mkt cap ! $35.43M

Open	High	Low	Value	Volume
4.1¢	4.4¢	4.0¢	$20.95K	507.0K

Buyers (Bids)

No.	Vol.	Price($)
8	216927	4.0¢

Sellers (Offers)

Price($)	Vol.	No.
4.4¢	238807	2

View Market Depth

No.	Vol.	Price($)
8	216927	0.040
4	374358	0.039
3	750222	0.038
9	742682	0.037
7	598944	0.036

Price($)	Vol.	No.
0.044	238807	2
0.045	423919	4
0.046	298002	2
0.047	488389	2
0.048	200000	1

Last trade - 16.10pm 09/07/2024 (20 minute delay)

PTX (ASX) Chart

Daily happenings?., page-524

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Daily happenings?., page-524

Top Stories

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News